POT-4

· Potentia Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for POT-4, covering 2010-03-18 to 2010-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD) [Phase 1]

See pricing